AN2 Therapeutics
Yahoo Finance • 21 days ago
AN2 Therapeutics reports Q3 results
* AN2 Therapeutics press release [https://seekingalpha.com/pr/20304970-an2-therapeutics-reports-third-quarter-2025-financial-results-and-recent-business-and] (ANTX [https://seekingalpha.com/symbol/ANTX]): Q3 net loss was $9.4 million.... Full story
Yahoo Finance • 4 months ago
AN2 Therapeutics’ SWOT analysis: stock’s potential amid pipeline setbacks
AN2 Therapeutics, Inc. (NASDAQ:ANTX), a biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases, finds itself at a critical juncture following recent clinical trial results and strategi... Full story
